Geoff Oxnard
Net worth: 277 446 $ as of 2026-07-30
Net worth: 277 446 $ as of 2026-07-30
Dr. Geoff Oxnard, MD, is a Chief Medical Officer & Executive Vice President at Blossomhill Therapeutics, Inc. Dr. Oxnard was previously employed as a Vice President & Global Head-Thoracic Cancers by Eli Lilly & Co. and a Senior Vice President & Head-Clinical Development by F.
Hoffmann-La Roche Ltd. He received his undergraduate degree from Harvard University and a doctorate degree from Pritzker School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-05 | 17,785 ( 0.06% ) | 277 446 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-12-31 |
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2024-12-31 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2023-08-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions